EG24413A - Compound which inhibit the release of inflammatory cytokines - Google Patents

Compound which inhibit the release of inflammatory cytokines

Info

Publication number
EG24413A
EG24413A EG2002091039A EG2002091039A EG24413A EG 24413 A EG24413 A EG 24413A EG 2002091039 A EG2002091039 A EG 2002091039A EG 2002091039 A EG2002091039 A EG 2002091039A EG 24413 A EG24413 A EG 24413A
Authority
EG
Egypt
Prior art keywords
inhibit
release
compound
inflammatory cytokines
cytokines
Prior art date
Application number
EG2002091039A
Other languages
English (en)
Inventor
Michael P Clark
Matthew J Laufersweiler
Jane F Djung
Biswanath De
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of EG24413A publication Critical patent/EG24413A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/20Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
EG2002091039A 2001-09-20 2002-09-21 Compound which inhibit the release of inflammatory cytokines EG24413A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32362501P 2001-09-20 2001-09-20

Publications (1)

Publication Number Publication Date
EG24413A true EG24413A (en) 2009-05-25

Family

ID=23259997

Family Applications (2)

Application Number Title Priority Date Filing Date
EG2002091039A EG24413A (en) 2001-09-20 2002-09-21 Compound which inhibit the release of inflammatory cytokines
EG2002091037A EG24363A (en) 2001-09-20 2002-09-21 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokiness

Family Applications After (1)

Application Number Title Priority Date Filing Date
EG2002091037A EG24363A (en) 2001-09-20 2002-09-21 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokiness

Country Status (33)

Country Link
US (2) US6566357B1 (es)
EP (3) EP1427728B1 (es)
JP (3) JP2005504082A (es)
KR (4) KR20040035837A (es)
CN (3) CN1257905C (es)
AR (3) AR037145A1 (es)
AT (3) ATE332901T1 (es)
AU (2) AU2002327690B2 (es)
BR (3) BR0212905A (es)
CA (3) CA2461073A1 (es)
CO (3) CO5560589A2 (es)
CY (1) CY1106398T1 (es)
CZ (3) CZ2004358A3 (es)
DE (3) DE60218704T2 (es)
DK (2) DK1427732T3 (es)
EG (2) EG24413A (es)
ES (3) ES2282459T3 (es)
HK (2) HK1071366A1 (es)
HU (3) HUP0402378A3 (es)
IL (3) IL160682A0 (es)
MA (3) MA27066A1 (es)
MX (3) MXPA04002569A (es)
MY (2) MY129329A (es)
NO (2) NO20041594L (es)
NZ (3) NZ531122A (es)
PE (3) PE20030474A1 (es)
PL (3) PL370351A1 (es)
PT (3) PT1427727E (es)
RU (3) RU2299885C2 (es)
SA (1) SA03230529B1 (es)
SK (3) SK1482004A3 (es)
WO (3) WO2003024970A1 (es)
ZA (3) ZA200401260B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087615B2 (en) 2001-09-20 2006-08-08 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia
US6849627B2 (en) 2001-09-20 2005-02-01 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7473695B2 (en) * 2001-10-22 2009-01-06 Mitsubishi Tanabe Pharma Corporation 4-imidazolin-2-one compounds
US6677337B2 (en) * 2002-03-19 2004-01-13 The Procter & Gamble Company 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines
CA2497007A1 (en) * 2002-09-09 2004-03-18 Amgen Inc. 1, 4, 5-substituted 1, 2-dihydro-pyrazol-3-one and 3-alkoxy-1h-pyrazole derivatives s tnf-alpha and interleukin lowering agents for the treatment of inflammations
KR20050109617A (ko) * 2003-04-03 2005-11-21 메르크 파텐트 게엠베하 혈전증 치료용 응집 인자 xa 저해제로서의피라졸리딘-1,2-디카르복실디페닐아미드 유도체
GB0308466D0 (en) * 2003-04-11 2003-05-21 Novartis Ag Organic compounds
US7482356B2 (en) * 2003-11-10 2009-01-27 The Procter & Gamble Company Bicyclic pyrazolone cytokine inhibitors
KR20080111144A (ko) * 2006-04-18 2008-12-22 아보트 러보러터리즈 바닐로이드 수용체 서브타입 1(vr1)의 길항제 및 이의 용도
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
EP2432767B1 (en) * 2009-05-19 2013-06-26 Dow AgroSciences LLC Compounds and methods for controlling fungi
EP3308059B1 (en) 2015-06-15 2021-05-26 Cummins, Inc. Combustion chamber elasticity device
US20190060286A1 (en) 2016-02-29 2019-02-28 University Of Florida Research Foundation, Incorpo Chemotherapeutic Methods
CN107033090B (zh) * 2017-05-16 2019-05-07 无锡捷化医药科技有限公司 一种1,2,3,4-四氢噌啉的制备方法
RU2721684C1 (ru) * 2019-09-06 2020-05-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" Метил 2,3,8-триоксо-4-фенилтетрагидро-6Н-пиразоло[1,2-а]пирроло[2,3-c]пиразол-9а(1Н)-карбоксилаты
WO2023076133A1 (en) * 2021-10-27 2023-05-04 Merck Sharp & Dohme Llc Spirotricycle ripk1 inhibitors and methods of uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054291A (es) * 1963-02-26
GB1124982A (en) * 1965-02-09 1968-08-21 Lepetit Spa Diazabicyclo octanes and derivatives thereof
CH529153A (fr) 1969-10-27 1972-10-15 Lepetit Spa Procédé de préparation de pyrazolo (1,2-b) phtalazine-1,5 (10H)-diones
US5358924A (en) * 1991-03-21 1994-10-25 Bayer Aktiengesellschaft 3-hydroxy-4-aryl-5-oxo-pyrozoline derivatives, compositions and use
HU229958B1 (hu) * 1999-09-07 2015-03-30 Syngenta Participations Ag Herbicid vegyületek, ezeket tartalmazó készítmények, eljárás a vegyületek előállítására, valamint eljárás gyomnövények irtására
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

Also Published As

Publication number Publication date
CA2461072A1 (en) 2003-03-27
AR037145A1 (es) 2004-10-27
KR20060036125A (ko) 2006-04-27
CN1249066C (zh) 2006-04-05
EP1427727A1 (en) 2004-06-16
DE60202782T2 (de) 2006-01-19
AR037502A1 (es) 2004-11-17
BR0212716A (pt) 2004-08-03
US6566357B1 (en) 2003-05-20
MA27066A1 (fr) 2004-12-20
ATE356126T1 (de) 2007-03-15
BR0212673A (pt) 2004-08-24
PL370415A1 (en) 2005-05-30
AR037237A1 (es) 2004-11-03
EP1427732A1 (en) 2004-06-16
MXPA04002570A (es) 2004-05-31
NZ531123A (en) 2006-08-31
RU2272040C2 (ru) 2006-03-20
RU2299885C2 (ru) 2007-05-27
CZ2004358A3 (cs) 2004-07-14
CA2461071A1 (en) 2003-03-27
NZ531122A (en) 2005-09-30
EP1427727B1 (en) 2005-01-26
JP2005504083A (ja) 2005-02-10
EG24363A (en) 2009-03-04
CZ2004361A3 (cs) 2004-07-14
ATE287887T1 (de) 2005-02-15
DK1427732T3 (da) 2006-10-30
IL160741A0 (en) 2004-08-31
NO20041605L (no) 2004-06-21
CN1555379A (zh) 2004-12-15
PT1427732E (pt) 2006-12-29
CZ2004345A3 (cs) 2004-06-16
PT1427727E (pt) 2005-06-30
KR100623879B1 (ko) 2006-09-19
MXPA04002574A (es) 2004-06-18
PL370351A1 (en) 2005-05-16
CA2461073A1 (en) 2003-03-27
ES2282459T3 (es) 2007-10-16
HUP0402378A2 (hu) 2005-02-28
DE60213108T2 (de) 2007-02-08
HUP0402500A2 (hu) 2005-03-29
SK1482004A3 (en) 2004-08-03
PE20030430A1 (es) 2003-06-24
CO5560579A2 (es) 2005-09-30
WO2003024970A1 (en) 2003-03-27
ES2237691T3 (es) 2005-08-01
EP1427732B1 (en) 2006-07-12
CO5560589A2 (es) 2005-09-30
ZA200401260B (en) 2004-08-30
JP2005504082A (ja) 2005-02-10
MA27064A1 (fr) 2004-12-20
HUP0402378A3 (en) 2008-10-28
RU2004111805A (ru) 2005-04-10
MA27065A1 (fr) 2004-12-20
WO2003024973A1 (en) 2003-03-27
ZA200401403B (en) 2004-08-30
IL160682A0 (en) 2004-08-31
PL370362A1 (en) 2005-05-16
ES2268154T3 (es) 2007-03-16
DK1427728T3 (da) 2007-07-09
HUP0402500A3 (en) 2008-10-28
RU2004111806A (ru) 2005-03-27
CN1555375A (zh) 2004-12-15
SK1492004A3 (en) 2004-11-03
ATE332901T1 (de) 2006-08-15
HK1071565A1 (en) 2005-07-22
KR20040035835A (ko) 2004-04-29
MY129329A (en) 2007-03-30
RU2004111803A (ru) 2005-10-10
EP1427728A1 (en) 2004-06-16
CO5560590A2 (es) 2005-09-30
WO2003024971A1 (en) 2003-03-27
NO20041594L (no) 2004-06-21
PT1427728E (pt) 2007-05-31
DE60218704T2 (de) 2007-11-08
DE60202782D1 (de) 2005-03-03
MXPA04002569A (es) 2004-05-31
SK1502004A3 (en) 2004-09-08
NZ531063A (en) 2007-08-31
HUP0500752A2 (en) 2006-01-30
MY129069A (en) 2007-03-30
HK1071366A1 (en) 2005-07-15
SA03230529B1 (ar) 2008-06-21
CY1106398T1 (el) 2011-10-12
KR20040035837A (ko) 2004-04-29
JP2005504081A (ja) 2005-02-10
CN1257905C (zh) 2006-05-31
PE20030446A1 (es) 2003-07-21
DE60213108D1 (de) 2006-08-24
EP1427728B1 (en) 2007-03-07
AU2002334641B2 (en) 2007-03-29
DE60218704D1 (de) 2007-04-19
CN1250551C (zh) 2006-04-12
RU2278864C2 (ru) 2006-06-27
US20030105084A1 (en) 2003-06-05
PE20030474A1 (es) 2003-07-22
AU2002327690B2 (en) 2006-07-20
ZA200401402B (en) 2004-08-27
KR20040035836A (ko) 2004-04-29
KR100656126B1 (ko) 2006-12-12
US6821971B2 (en) 2004-11-23
IL160742A0 (en) 2004-08-31
BR0212905A (pt) 2004-10-13
CN1556811A (zh) 2004-12-22

Similar Documents

Publication Publication Date Title
EP1395240A4 (en) MODIFYING THE DELAYED RELEASE PROFILE
EG24413A (en) Compound which inhibit the release of inflammatory cytokines
EP1402223A4 (en) MOUTH BRAKE
GB0218157D0 (en) Compositions for controlled release
HK1084043A1 (en) Derivatives of aryl-quinazoline/aryl-2amino-phenylmethanone which promote the release of parathyroidhormone
GB0114198D0 (en) Herbicidal composition
PL366891A1 (en) Herbicidal composition
IS6889A (is) Ímídazólýl afleiður sem tálmar kortíkótrópíns losunarþátts
ZA200500741B (en) Compositions against inflammatory processes
PL383682A1 (pl) Sposób hydrocyjanowania olefinowo nienasyconego związku
HUP0303245A3 (en) Herbicidal composition
PL368002A1 (en) Herbicidal composition
GB0118517D0 (en) Compound
EP1415655A4 (en) IMMUNOTHERAPY FOR PEOPLE
AU2002362498A8 (en) Herbicidal composition
GB0127923D0 (en) Compound
PL368810A1 (en) Herbicidal composition
PL369829A1 (en) Substituted 1h-quinolin-2-one compounds
AU2002359382A1 (en) Quick release assembly
IL161178A0 (en) MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
GB0122326D0 (en) Palmerstone ceramic compound
PL368037A1 (en) Herbicidal composition
TW581334U (en) The compound structure of terminal
DK1427727T3 (da) Forbindelser, der hæmmer frigörelse af inflammatoriske cytokiner
AU2002237187A1 (en) The inflammatory inhibition factor fwa116